Frontlight ResearchEarly access
Trial site
Institut public de cancérologie Strauss Europe
- 12running trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 26 trials
- Phase 34 trials
- Phase 41 trial
- Status
- Recruiting7 trials
- Not yet recruiting4 trials
- Active, not recruiting1 trial
- Lead sponsor
- Unicancer3 trials
- Groupe Oncologie Radiotherapie Tete et Cou2 trials
- Association Gercor1 trial
- Centre Paul Strauss1 trial
- Hospices Civils de Lyon1 trial
- and 4 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer2 recruiting
- Prostate cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026